SMTL ID : 5jfo.1

Structure of the M.tuberculosis enoyl-reductase InhA in complex with GSK625

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.91 Å

Oligo State

homo-tetramer

Ligands

4 x NAD: NICOTINAMIDE-ADENINE-DINUCLEOTIDE(Non-covalent)

NAD.1: 23 residues within 4Å: Chain A: G.14, I.15, I.16, S.20, I.21, F.41, L.63, D.64, V.65, S.94, I.95, G.96, I.122, M.147, D.148, F.149, K.165, A.191, G.192, P.193, I.194, T.196 Ligands: 6KA.2 16 PLIP interactions: 16 interactions with chain A Hydrophobic interactions: A:F.149, A:A.191 Hydrogen bonds: A:G.14, A:S.20, A:I.21, A:D.64, A:D.64, A:V.65, A:I.95, A:G.96, A:K.165, A:I.194, A:I.194, A:T.196 Water bridges: A:S.94 pi-Stacking: A:F.41 NAD.3: 24 residues within 4Å: Chain B: G.14, I.15, I.16, S.20, I.21, F.41, L.63, D.64, V.65, S.94, I.95, G.96, I.122, M.147, D.148, F.149, K.165, A.191, G.192, P.193, I.194, T.196, M.199 Ligands: 6KA.4 16 PLIP interactions: 16 interactions with chain B Hydrophobic interactions: B:F.149, B:F.149 Hydrogen bonds: B:G.14, B:S.20, B:I.21, B:D.64, B:D.64, B:V.65, B:I.95, B:G.96, B:K.165, B:I.194, B:I.194, B:T.196 Water bridges: B:S.94 pi-Stacking: B:F.41 NAD.5: 24 residues within 4Å: Chain C: G.14, I.15, I.16, S.20, I.21, F.41, L.63, D.64, V.65, S.94, I.95, G.96, F.97, I.122, M.147, D.148, F.149, K.165, A.191, G.192, P.193, I.194, T.196 Ligands: 6KA.6 17 PLIP interactions: 17 interactions with chain C Hydrophobic interactions: C:F.149, C:A.191 Hydrogen bonds: C:G.14, C:S.20, C:S.20, C:I.21, C:D.64, C:V.65, C:I.95, C:G.96, C:K.165, C:I.194, C:I.194, C:T.196 Water bridges: C:F.41, C:S.94 pi-Stacking: C:F.41 NAD.7: 24 residues within 4Å: Chain D: G.14, I.15, I.16, S.20, I.21, F.41, L.63, D.64, V.65, S.94, I.95, G.96, I.122, M.147, D.148, F.149, K.165, A.191, G.192, P.193, I.194, T.196, M.199 Ligands: 6KA.8 14 PLIP interactions: 14 interactions with chain D Hydrophobic interactions: D:I.21, D:F.149 Hydrogen bonds: D:G.14, D:S.20, D:I.21, D:D.64, D:V.65, D:I.95, D:G.96, D:K.165, D:I.194, D:T.196 pi-Stacking: D:F.41, D:F.41

4 x 6KA: N-{1-[(2-chloro-6-fluorophenyl)methyl]-1H-pyrazol-3-yl}-5-[(1S)-1-(3-methyl-1H-pyrazol-1-yl)ethyl]-1,3,4-thiadiazol-2-amine(Non-covalent)

6KA.2: 14 residues within 4Å: Chain A: G.96, F.97, M.98, Q.100, M.103, G.104, F.149, Y.158, M.161, A.198, M.199, I.202, L.207 Ligands: NAD.1 6 PLIP interactions: 6 interactions with chain A Hydrophobic interactions: A:M.103, A:F.149, A:I.202 Hydrogen bonds: A:M.98, A:M.98 pi-Stacking: A:Y.158 6KA.4: 15 residues within 4Å: Chain B: G.96, F.97, M.98, Q.100, M.103, G.104, F.149, A.157, Y.158, M.161, A.198, M.199, I.202, I.215 Ligands: NAD.3 9 PLIP interactions: 9 interactions with chain B Hydrophobic interactions: B:Q.100, B:M.103, B:F.149, B:A.157, B:I.202, B:I.215 Hydrogen bonds: B:M.98, B:M.98 pi-Stacking: B:Y.158 6KA.6: 15 residues within 4Å: Chain C: G.96, F.97, M.98, Q.100, M.103, G.104, F.149, Y.158, M.161, A.198, M.199, I.202, L.207, I.215 Ligands: NAD.5 8 PLIP interactions: 8 interactions with chain C Hydrophobic interactions: C:M.103, C:F.149, C:Y.158, C:I.202, C:I.215 Hydrogen bonds: C:M.98, C:M.98 pi-Stacking: C:Y.158 6KA.8: 13 residues within 4Å: Chain D: G.96, F.97, M.98, Q.100, M.103, G.104, A.157, Y.158, M.161, A.198, M.199, I.202 Ligands: NAD.7 6 PLIP interactions: 6 interactions with chain D Hydrophobic interactions: D:M.103, D:A.157, D:I.202 Hydrogen bonds: D:M.98, D:M.98 pi-Stacking: D:Y.158

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Martinez-Hoyos, M. et al., Antitubercular drugs for an old target: GSK693 as a promising InhA direct inhibitor. Ebiomedicine (2016)

Release Date

2016-08-10

Peptides

Enoyl-[acyl-carrier-protein] reductase [NADH]: ABCD

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

C
C

D
D

Enoyl-[acyl-carrier-protein] reductase [NADH]

Related Entries With Identical Sequence